Dexcom (DXCM) director shifts 10,148 shares from direct ownership to revocable trust
Rhea-AI Filing Summary
Dexcom Inc. director Richard Alexander Collins reported internal share transfers involving 10,148 shares of common stock. On 2026-05-08, 5,074 shares moved from his direct ownership to the Richard A. Collins Revocable Trust, with both legs reported as bona fide gifts. After these entries, he holds 40,162 Dexcom shares indirectly through the trust and no shares directly.
Positive
- None.
Negative
- None.
Insights
Form 4 shows routine internal transfers, not market buying or selling.
Director Richard Alexander Collins reported two G-code (bona fide gift) transactions totaling 10,148 shares of Dexcom Inc. common stock. Footnotes explain these reflect a transfer from direct ownership into the Richard A. Collins Revocable Trust tied to vesting of restricted stock units.
Economically, this is a reclassification of how the shares are held, not an open-market trade. Following the transactions, Collins holds 40,162 shares indirectly via the trust and zero directly. With no shares bought or sold in the market, the filing is informational and does not, by itself, signal a change in his outlook on Dexcom.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 5,074 | $0.00 | $0.00 |
| Gift | Common Stock | 5,074 | $0.00 | $0.00 |
Footnotes (2)
- F1. Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units.
- F2. Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee.
Key Figures
Key Terms
bona fide gift financial
restricted stock units financial
revocable trust financial
indirect ownership financial
AI-generated analysis. How Rhea-AI works. Not financial advice.